Can We Quantitatively Assess Macroangiopathy Development in Patients with Type 2 Diabetes?

被引：0
|
作者：
Niwa, Hirokatsu
Dannoura, Midori
Oomori, Kazuno
Takahashi, Kiyohiko
Miyoshi, Arina
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
419-P
引用
收藏
页码：A111 / A111
页数：1
相关论文
共 50 条
  • [41] Should we treat patients with type 2 diabetes with glitazones?
    Vaillant-Roussel, Helene
    Nicot, Philippe
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2008, (80): : 12S - 13S
  • [42] Can we prevent type-2 diabetes: After the DPP study
    Slama, G
    ANNALES D ENDOCRINOLOGIE, 2003, 64 (03) : S3 - S6
  • [43] Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes?
    Buse, John B.
    D'Alessio, David A.
    Riddle, Matthew C.
    DIABETES CARE, 2018, 41 (08) : 1560 - 1562
  • [44] Sleeve gastrectomy in type 2 diabetes: can we improve case selection?
    Krishnamoorthy, Ashwin
    Koshy, Renol
    Munasinghe, Aruna
    Joseph, Sharin
    Jenkins, Lydia
    Griffin, Ellana
    Abraham, Jenny
    Shah, Neha
    Lam, For Tai
    Menon, Vinod
    BRITISH JOURNAL OF SURGERY, 2017, 104 : 25 - 25
  • [45] Development and validation of the Diabetes Obstacles Questionnaire (DOQ) to assess obstacles in living with Type 2 diabetes
    Hearnshaw, H.
    Wright, K.
    Dale, J.
    Sturt, J.
    Vermeire, E.
    van Royen, P.
    DIABETIC MEDICINE, 2007, 24 (08) : 878 - 882
  • [46] Relationship between advanced microangiopathy and macroangiopathy among patients with type 1 diabetes in Japan
    Sano, H
    Nishimura, R
    Agata, T
    Matsudaira, T
    Miyashita, Y
    Shimizu, H
    Tajima, N
    DIABETES, 2005, 54 : A576 - A576
  • [47] Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?
    Abdulameer, Shaymaa Abdalwahed
    Sulaiman, Syed Azhar Syed
    Hassali, Mohamed Azmi Ahmad
    Subramaniam, Karuppiah
    Sahib, Mohanad Naji
    PATIENT PREFERENCE AND ADHERENCE, 2012, 6 : 435 - 448
  • [48] The risk factors of early arterial stiffness in type 2 diabetes without diabetic macroangiopathy
    Jia-Hui Wu
    Rui Wang
    Xiao-Jiao Jia
    Na Lu
    Qiang Lu
    Fu-Zai Yin
    Chun-Ming Ma
    International Journal of Diabetes in Developing Countries, 2024, 44 : 271 - 277
  • [49] How can we best assess patients with globus symptoms?
    Conroy, Katherine R.
    Wilson, Janet A.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (01) : 6 - 7
  • [50] Methylenetetrahydrofolate reductase gene polymorphism, homocysteine and risk of macroangiopathy in Type 2 diabetes mellitus
    Sun, J.
    Xu, Y.
    Zhu, Y.
    Lu, H.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2006, 29 (09) : 814 - 820
12345